John Patience - May 21, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: Director, Chairman
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Stock symbol: BDSX
Transactions as of: May 21, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/23/2024, 07:12 PM
Previous filing: May 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+217K	+4.71%		4.83M	May 23, 2024	By John Patience Living Trust dated 7/23/1993	F1, F2
holding	BDSX	Common Stock						338K	May 21, 2024	Direct
holding	BDSX	Common Stock						2.08M	May 21, 2024	By Patience Enterprises LP	F3
holding	BDSX	Common Stock						53K	May 21, 2024	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Award	$0	+46.7K		$0.00	46.7K	May 21, 2024	Common Stock	46.7K		Direct	F4, F5
transaction	BDSX	Stock Options (Right to Buy)	Award	$0	+37.1K		$0.00	37.1K	May 21, 2024	Common Stock	37.1K	$1.57	Direct	F6
transaction	BDSX	Series A Non-Voting Convertible Preferred Stock	Options Exercise	$0	-5.44K	-100%	$0.00^*	0	May 23, 2024	Common Stock	217K		By John Patience Living Trust dated 7/23/1993	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
F2	The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
F3	The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
F5	These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
F6	This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.